Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Keybanc Maintains Underweight on WestRock, Lowers Price Target to $36

Keybanc analyst Adam Josephson maintains WestRock (NYSE:WRK) with a Underweight and lowers the price target from $44 to $36.
byBenzinga Newsdesk
July 1, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Keybanc analyst Adam Josephson maintains WestRock (NYSE:WRK) with a Underweight and lowers the price target from $44 to $36.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Cresco Labs And Temple University Join Forces To Research The Untapped Medical Benefits Of Cannabis

By Maureen Meehan
August 18, 4:11 PM
Temple University has been investigating the medical potential of cannabis for decades. Now, thanks to a new partnership with medical cannabis producer Cresco Labs (OTCQX: CRLBF), Temple is expanding its research into the ways cannabis can be used to treat conditions like chronic pain and food allergies.

CRLBF